Clinical Trial Update: Mycophenolate Mofetil for the Prophylaxis of Graft-versus-host Disease in High Risk Allogeneic Stem Cell Transplantation [NA]

View source ↗

Summary

This clinical trial update evaluates mycophenolate mofetil for preventing graft-versus-host disease in high-risk allogeneic stem cell transplantation. The curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation | NA | Status: UNKNOWN